APA (7th ed.) Citation

M, S., F, M., S, B., G, P., M, M., U, D. G., . . . N, B. (2021). Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor? Diagnostics (Basel, Switzerland), 11(1), . https://doi.org/10.3390/diagnostics11010138

Chicago Style (17th ed.) Citation

M, Santoni, et al. "Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor?" Diagnostics (Basel, Switzerland) 11, no. 1 (2021). https://doi.org/10.3390/diagnostics11010138.

MLA (9th ed.) Citation

M, Santoni, et al. "Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor?" Diagnostics (Basel, Switzerland), vol. 11, no. 1, 2021, https://doi.org/10.3390/diagnostics11010138.